Nephrology

Researchers discovered that dapagliflozin helped patients with and without diabetes in improving kidney disease.

Study found children with a new diagnosis of type 1 diabetes experienced higher rates of diabetic ketoacidosis in the COVID-19 pandemic.

Metformin is often associated with lactic acidosis, especially in patients with kidney disease. A recently published study questions this association in patients with mild to moderate disease.

Are you doing everything you can to ensure your patient has the best quality of life possible with type 2 diabetes?

SGLT-2 inhibitors show additional benefits besides lowering blood glucose.

The association between 1-year changes in albuminuria and subsequent risk of cardiovascular and renal events. 

Results of an extensive retrospective study indicate a strong association between glomerular filtration (eGFR) rate and cardiovascular disease morbidity rate.

A two-for-one deal: both cardiovascular benefits and renal protection.

Just one incident of DKA could potentially damage memory in children with type 1 diabetes.

A diabetes patient’s risk for chronic kidney disease or cardiovascular disease can be impacted by various factors, including ethnic background.